Literature DB >> 16255680

Investigations on gossypol: past and present developments.

Kalliopi Dodou1, Rosaleen J Anderson, David A P Small, Paul W Groundwater.   

Abstract

Gossypol has received significant attention as a result of its potential therapeutic application as a male antifertility agent. Furthermore, recent research examining the biological activity of gossypol has revealed a number of other promising lines of enquiry. These have focused on the antitumour, antiviral and antioxidant actions of the compound in various disease states. This article provides an overview of the studies on the biological activity of gossypol, with particular attention paid to the mechanisms of its activity and its prospect as a medicinal product.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16255680     DOI: 10.1517/13543784.14.11.1419

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  28 in total

Review 1.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

2.  AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.

Authors:  B S Yurekli; B Karaca; A Kisim; E Bozkurt; H Atmaca; S Cetinkalp; G Ozgen; C Yilmaz; S Uzunoglu; R Uslu; F Saygili
Journal:  J Endocrinol Invest       Date:  2017-07-20       Impact factor: 4.256

Review 3.  Biomarkers of therapeutic response to BCL2 antagonists in cancer.

Authors:  Lloyd T Lam; Haichao Zhang; Brenda Chyla
Journal:  Mol Diagn Ther       Date:  2012-12       Impact factor: 4.074

4.  Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.

Authors:  Suresh R Volate; Brian T Kawasaki; Elaine M Hurt; John A Milner; Young S Kim; Jeffrey White; William L Farrar
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

5.  Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells.

Authors:  Kumudha Balakrishnan; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

Review 6.  Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.

Authors:  Camilla Krakstad; Martha Chekenya
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

7.  The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis.

Authors:  Wen-bin Xu; Li-hui Xu; Hong-song Lu; Dong-yun Ou-Yang; Huan-jing Shi; Jing-fang Di; Xian-hui He
Journal:  Acta Pharmacol Sin       Date:  2009-04-13       Impact factor: 6.150

8.  How to train glioma cells to die: molecular challenges in cell death.

Authors:  Jeffrey Wojton; Walter Hans Meisen; Balveen Kaur
Journal:  J Neurooncol       Date:  2015-11-05       Impact factor: 4.130

Review 9.  A natural history of botanical therapeutics.

Authors:  Barbara Schmidt; David M Ribnicky; Alexander Poulev; Sithes Logendra; William T Cefalu; Ilya Raskin
Journal:  Metabolism       Date:  2008-07       Impact factor: 8.694

10.  Next generation sequencing and de novo transcriptome analysis of Costus pictus D. Don, a non-model plant with potent anti-diabetic properties.

Authors:  Ramasamy S Annadurai; Vasanthan Jayakumar; Raja C Mugasimangalam; Mohan A V S K Katta; Sanchita Anand; Sreeja Gopinathan; Santosh Prasad Sarma; Sunjay Jude Fernandes; Nandita Mullapudi; S Murugesan; Sudha Narayana Rao
Journal:  BMC Genomics       Date:  2012-11-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.